Feed LNSR
LN

LENSAR, Inc.

LNSR · NASDAQ

$7.25 -0.68% (-$0.05)
1M -21.45%
Market Cap $89.0M
P/E Ratio 2.57x
Div. Yield -
ROE -
Piotroski F-Score Moderate
5/9
Valuation
87 /100
Cheap
P/E 2.57x
P/B 5.97x
EV/EBITDA 2.19x
Growth
100 /100
Growing
Rev. growth 18.23%
EPS growth N/A
Book val. growth N/A
Profitability
39 /100
Moderate
Gross margin 47.96%
FCF margin 12.16%
Net margin 57.57%
Quality
37 /100
Average
ROIC 22.01%
Asset turnover 0.87x
ROA 49.88%
Debt
100 /100
Low
Debt/Equity 0.16x
Net debt/EBITDA -0.31x
Current ratio 2.39x
Stability
55 /100
Moderate
Beta 0.97x
Profitable years 0
Rev. volatility 8.84%

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Ask StockBot about LNSR
Online

About the company

LENSAR, Inc. (LSR) is an American company focused on the development and manufacturing of advanced technologies for surgical ophthalmology. With a product portfolio including innovative surgical systems like the LENSAR® Laser System, LENSAR provides state-of-the-art solutions for cataract procedures. Their technology combines advanced robotics, 3D imaging, and laser energy, enabling precise and personalized surgical interventions for patients. LENSAR, Inc. also emphasizes continuous development and innovation in the field of ophthalmic surgery. Shares of LENSAR, Inc. (LSR) could be suitable for investors seeking opportunities in the healthcare technology sector with a focus on ophthalmic surgery and innovative technologies.

Sector

Healthcare

Industry

Medical - Devices

CEO

Nicholas T. Curtis

Employees

150

Headquarters

Orlando

Upcoming events

12 NOV

Earnings

Upcoming earnings report

50d

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.